SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-110839
Filing Date
2016-03-28
Accepted
2016-03-28 21:26:07
Documents
2
Period of Report
2016-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4323
2 POA DOCUMENT poa.txt EX-24.4_645055 3101
  Complete submission text file 0001209191-16-110839.txt   8901
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-272-6138
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 330971591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 350 CAMBRIDGE AVE, SUITE 350 PALO ALTO CA 94306
Business Address
Martins Eduardo Bruno (Reporting) CIK: 0001670431 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 161533459